Home pageSTAR • NSE
add
Strides Pharma Science Ltd
Chiusura precedente
628,45 ₹
Intervallo giornaliero
627,40 ₹ - 650,95 ₹
Intervallo annuale
329,86 ₹ - 804,00 ₹
Cap di mercato
58,80Â Mld INR
Volume medio
939.516,00
Rapporto P/E
21,79
Dividendo/Prezzo
0,39%
Borsa valori principale
NSE
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Entrate | 11,54Â Mld | 11,18% |
Spese di gestione | 5,12Â Mld | 7,98% |
Utile netto | 879,46Â Mln | 77,07% |
Margine di profitto netto | 7,62 | 59,08% |
Utili per azione | — | — |
EBITDA | 2,06Â Mld | 7,44% |
Aliquota fiscale effettiva | 20,91% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 2,47Â Mld | -24,31% |
Totale attivo | — | — |
Totale passivo | — | — |
Patrimonio netto totale | 22,15 Mld | — |
Azioni in circolazione | 91,99 Mln | — |
Prezzo/valore contabile | 2,54 | — |
Redditività dell'attivo | — | — |
Rendimento sul capitale | 8,95% | — |
Flusso di cassa
Flusso di cassa netto
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 879,46Â Mln | 77,07% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Fondazione
1990
Sito web
Dipendenti
3.065